Evidence map›Paper›PMID 39372512›Full record

ArticleApplied biosafety : journal of the American Biological Safety Association2024

Substitution Attacks: A Catalyst to Reframe the DNA Manufacturing Cyberbiosecurity Landscape in the Age of Benchtop Synthesizers.

Laura Adam, George H McArthur

Abstract read
In one paragraph

Article in Applied biosafety : journal of the American Biological Safety Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Why implementation gaps could undermine synthetic nucleic acid oversight.Frontiers in bioengineering and biotechnology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Laura AdamBuilt Biotechnologies Inc., Charlottesville, Virginia, USA.ORCID https://orcid.org/0000-0002-4822-2695
George H McArthurBuilt Biotechnologies Inc., Charlottesville, Virginia, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The advent of easy-to-use benchtop DNA synthesizers has ushered in a transformative era in biotechnology, extending the capabilities of DNA synthesis to nonspecialists. However, this revolution in access to this technology exposes several vulnerabilities, notably in the form of substitution attacks. These attacks exploit the intricate interplay between the digital domain of DNA sequences and the physical reality of synthesis instruments, posing substantial threats to biosecurity. Content: This article delves deeply into the dynamic and multifaceted landscape of cyberbiosecurity, specifically emphasizing a novel attack vector that evades traditional screening algorithms. To achieve this, the article explores algorithmic approaches designed to screen DNA sequences, shedding light on the vulnerabilities exposed by substitution attacks and recontextualizing the cyberbiosecurity actor landscape in the context of the entire DNA manufacturing process. Summary: The exploration of cyberbiosecurity brings existing vulnerabilities in DNA screening algorithms to light and sets the stage for future research and policy considerations. By emphasizing opportunities for a comprehensive, multipronged approach rooted in end-to-end practical DNA manufacturing, this study provides a foundation for advancing both knowledge and strategies in the realm of cyberbiosecurity. Recommendations: This article serves as a clarion call for increased vigilance and innovation in navigating the intricate landscape of cyberbiosecurity. Effectively understanding and mitigating substitution attacks is necessary to safeguard the integrity of synthesized genetic material, particularly in the context of the democratization of DNA synthesis technology.

Indexed as

bioinformaticsbiosecuritycyberbiosecurityDNA sequencingDNA synthesis

Identifiers

PMID39372512
PMCPMC11447128

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.